Liquidia Technologies, Inc. (LQDA): Price and Financial Metrics
LQDA Price/Volume Stats
| Current price | $18.02 | 52-week high | $19.41 |
| Prev. close | $17.60 | 52-week low | $8.26 |
| Day low | $17.47 | Volume | 2,893,200 |
| Day high | $18.43 | Avg. volume | 1,270,047 |
| 50-day MA | $15.01 | Dividend yield | N/A |
| 200-day MA | $12.78 | Market Cap | 1.54B |
LQDA Stock Price Chart Interactive Chart >
Liquidia Technologies, Inc. (LQDA) Company Bio
Liquidia Technologies, Inc., a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of human therapeutics. Its lead product candidate, LIQ861, an inhaled dry powder formulation of treprostinil that is in Phase III clinical trials used for the treatment of pulmonary arterial hypertension. The company is also developing LIQ865, which completed Phase Ib clinical trials for the treatment of local post-operative pain. The company was founded in 2004 and is based in Morrisville, North Carolina.
LQDA Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
LQDA Price Returns
| 1-mo | 16.03% |
| 3-mo | 21.59% |
| 6-mo | 63.67% |
| 1-year | 29.45% |
| 3-year | 303.13% |
| 5-year | 138.36% |
| YTD | 53.23% |
| 2024 | -2.24% |
| 2023 | 88.85% |
| 2022 | 30.80% |
| 2021 | 65.08% |
| 2020 | -30.99% |